26 Jan 2026 DOCM.SW DocMorris AG (SIX) CHF5.40 -15.56% intraday: levels to watch

DOCM.SW stock slid -15.56% intraday to CHF 5.40 on 26 Jan 2026 on heavy volume, marking one of the top losers on the SIX Swiss Exchange. Traders hit the sell button after the stock opened at CHF 5.80 and printed a day low at CHF 5.40 on volume of 152,836 shares, versus an average of 333,479. The move widened the gap below the 200‑day average of CHF 7.81 and reinforced short‑term bearish momentum. Below we unpack what drove the drop, key support, valuation metrics and what investors should watch next.

Intraday price action and drivers

DOCM.SW stock fell sharply today on the SIX in Switzerland, closing near the day low at CHF 5.40 after a gap lower from the open at CHF 5.80. The intraday decline of -15.56% came with volume 152,836, a relative volume of 2.18, suggesting outsized selling pressure compared with the 50‑day average.

One clear driver: weak near‑term sentiment and continued negative earnings history (EPS -4.58) that keeps headline risk high ahead of the next earnings announcement on 19 Mar 2026. Market participants also cite valuation concerns versus sector peers despite a low price‑to‑sales ratio.

Fundamentals and valuation: why the drop matters

DocMorris AG (DOCM.SW) reports trailing metrics that help explain the market reaction. Market cap stands at CHF 278,959,517.00, EPS is -4.58, and reported PE is -1.25, reflecting negative earnings. Price to sales sits at 0.26 and price to book at 0.35, indicating the market is pricing in continued recovery risk.

Balance sheet strengths: cash per share is CHF 7.89 and current ratio is 3.25, which provide short‑term liquidity cover. Still, free cash flow per share is negative at -2.48, limiting near‑term upside until profitability stabilises.

Technical setup and key levels for traders

Technically, DOCM.SW hit intraday support at the year low zone near CHF 4.79 and faces immediate resistance at the 50‑day average CHF 5.66 and the Bollinger middle band CHF 5.78. Momentum indicators show RSI at 58.98, MACD histogram positive but thin, and ADX at 26.52, signalling a trending move.

For short‑term traders watch CHF 4.79 as a support pivot and CHF 6.50 as a first resistance. A clean break above CHF 7.81 (200‑day average) would be needed to shift bias back toward recovery.

Meyka AI grade and model forecast for DOCM.SW stock

Meyka AI rates DOCM.SW with a score of 60.04 out of 100 — Grade B (HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating highlights mixed fundamentals: low valuation multiples but ongoing negative earnings and cash flow.

Meyka AI’s forecast model projects a monthly level of CHF 3.72 (implied -31.11% vs current CHF 5.40) and a quarterly level of CHF 23.39 (implied +332.04% vs current). Forecasts are model‑based projections and not guarantees. Use these outputs as scenario inputs, not definitive targets.

Catalysts, sector context and risk factors

Catalysts that could move DOCM.SW include the 19 Mar 2026 earnings update, any guidance revisions, and operational news from DocMorris AG’s wider e‑commerce and wholesale channels. The Healthcare sector on the SIX is performing positively year‑to‑date, but DOCM.SW’s execution risk separates it from larger peers such as Roche and Novartis.

Key risks: continued negative EPS, subpar free cash flow, and concentrated retail/online competition. Near‑term upside will depend on margin improvement and clearer path to sustainable profits.

Short‑term trading strategy and suggested levels

For traders focusing on top losers, consider tactical rules: trim positions on rallies into CHF 6.50–CHF 7.80, and add only on confirmed support at CHF 4.80 with improving intraday volume patterns. Set tight risk controls: stop below CHF 4.70 for short trades and use scaled entries for longer ideas.

Analyst consensus is sparse; there is no formal price target consensus. We suggest a conservative 12‑month price target of CHF 8.00 as a scenario if margins recover and revenue stabilises, and a downside scenario to CHF 3.50 if losses continue.

Final Thoughts

DOCM.SW stock is a clear intraday loser on 26 Jan 2026 after a -15.56% drop to CHF 5.40, driven by weak profitability metrics (EPS -4.58, PE -1.25) and heavier than average volume 152,836. The balance sheet shows liquidity via cash per share CHF 7.89, but negative free cash flow and ongoing losses keep upside limited until operational signs improve. Meyka AI rates DOCM.SW 60.04 out of 100 (Grade B, HOLD) and flags mixed signals between low valuation and profit generation risk. Meyka AI’s forecast model projects CHF 3.72 (monthly) and CHF 23.39 (quarterly); these divergent outputs demonstrate model sensitivity to horizon and should not be viewed as guarantees. Traders should watch support at CHF 4.79 and resistance at CHF 6.50–CHF 7.81, and monitor the 19 Mar 2026 earnings release for fresh directional cues. Meyka AI provides this AI‑powered market analysis to help frame scenarios, not as investment advice

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.